The MoA of RUNX1 has been built specifically with regards to the pathophysiological motives–hepatic IR, lipotoxicity and hepatic injury & liver fibrosis–due to their high probability of relationship with RUNX1 and the previously known molecular information found in available scientific literature. Here, RUNX1 is linked to Hepatic fibrosis.